Literature DB >> 3510086

Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods.

S Yusuf, J Wittes, K Bailey, C Furberg.   

Abstract

Mesh:

Year:  1986        PMID: 3510086     DOI: 10.1161/01.cir.73.1.14

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  21 in total

1.  Therapeutic ranges of serum digoxin concentrations in patients with heart failure.

Authors:  Zachary D Goldberger; Ary L Goldberger
Journal:  Am J Cardiol       Date:  2012-04-11       Impact factor: 2.778

2.  Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.

Authors:  R Padrini; M Panfili; G Magnolfi; D Piovan; D Casarotto; M Ferrari
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 3.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 4.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 5.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

Review 6.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

7.  Digoxin--doubts to dampen enthusiasm.

Authors:  P A Poole Wilson
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

8.  Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.

Authors:  Andrew P Ambrosy; Ankeet S Bhatt; Amanda L Stebbins; Lisa M Wruck; Marat Fudim; Stephen J Greene; William E Kraus; Christopher M O'Connor; Ileana L Piña; David J Whellan; Robert J Mentz
Journal:  Am Heart J       Date:  2018-02-11       Impact factor: 4.749

Review 9.  Risks and benefits of the treatment of heart failure. Current status.

Authors:  J F Moran
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

Review 10.  Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.

Authors:  I Crozier; H Ikram
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.